Related Experiment Video
Updated: Oct 23, 2025

Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great
Denise Dunlap1, Roberto S Santos1, David D McManus2
1University of Massachusetts Lowell, USA.
Abstract:
The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distributed healthcare know-how. Without a cure for COVID-19, the ambiguity concerning how coronavirus-related policies will impact international business remains unclear. Through a multi-method approach, our study sheds light on two key healthcare industry trends: decentralization and deglobalization of clinical trials. We offer actionable strategies to not only mitigate these challenges, but also to take advantage of their new opportunities.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Current Trends in Nursing II
Drug Control Governance: Regulatory Bodies and Their Impact

